Wednesday 16 September 2015
Théâtre du Vaudeville, Brussels
Molecular Imaging is in a key position to bring personalized therapy into routine clinical practice. It can provide non-invasive tools to monitor and predict response to therapy, leading to improved quality of life while, at the same time, reduces healthcare costs.
• Wolfgang Weber, MD, Memorial Sloan Kettering Cancer Center, New York, USA
• Barry A. Siegel, MD, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA
• Elisabeth de Vries, MD, PhD, Faculty of Medical Sciences, Medical Oncology, Groningen, The Netherlands
• Barbara Malene Fischer, MD, PhD, DMSci, Dept. of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Denmark.
• Konrade von Bremen, MD, Inselspital, Bern, Switzerland,
• Antonis Kalemis, PhD, MBA, AIPES